Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > ASCEND and Ventripoint are up to exciting things!
View:
Post by jopatclo on Jul 16, 2024 1:53pm

ASCEND and Ventripoint are up to exciting things!

 

Feed post number 1

Ventripoint is now a part of ASCEND Cardiovascular‘s global distribution and marketing for cardiac diagnostic and imaging technologies. Ventripoint’s AI-powered diagnostic technology will be integrated into ASCEND Cardiovascular‘s IT for cardiovascular care for its current user base of over 50,000 hospitals and clinics. The collaboration marks a significant stepping stone for providing access to advanced care for patients and families.
Comment by jopatclo on Jul 16, 2024 3:50pm
With FDA V4.0 at any time and this good news Ascend cardiovascular Impressive just with Ascend Cardiovascular...  Ventripoint’s AI-powered diagnostic technology will be integrated into ASCEND Cardiovascular‘s IT for cardiovascular care for its current user base of over 50,000 hospitals and clinics. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities